Comment from American Association of Neurological Surgeons and Congress of Neurological Surgeons

Summary: The American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS) support the FDA's Commissioner’s National Priority Voucher (CNPV) Pilot Program and advocate for its expansion to include certain medical devices. They recommend implementing rigorous eligibility standards, requiring more detailed voucher submissions, establishing robust post-market oversight, and creating a metrics-driven framework to evaluate the program's performance.